Ascend Wellness Holdings (AAWH) Non-Current Assets (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Non-Current Assets came in at $683.1 million in Q1 2026, up 0.56% year-on-year from $679.4 million in Q1 2025, and down 2.27% quarter-over-quarter from $699.0 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Non-Current Assets (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Non-Current Assets history runs 7 years deep, the most recent figure standing at $683.1 million for Q1 2026.
- On a quarterly basis, Non-Current Assets rose 0.56% year-over-year to $683.1 million in Q1 2026; TTM through Mar 2026 was $1.9 billion, a 32.07% decrease from a year earlier, with the FY2025 full-year figure at $699.0 million, up 4.16% from the prior year.
- Non-Current Assets retreated to $683.1 million in Q1 2026 per AAWH's latest filing, from $699.0 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $699.0 million in Q4 2025 and bottomed at -$208.8 million in Q3 2025.
- The 5-year median for Non-Current Assets is $679.4 million (2025), against an average of $607.7 million.
- Across the five-year window, Non-Current Assets jumped 189.73% in 2022 and plunged 130.6% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $673.4 million in 2022, then gained by 2.56% to $690.7 million in 2023, then slipped by 2.84% to $671.1 million in 2024, then increased by 4.16% to $699.0 million in 2025, then slipped by 2.27% to $683.1 million in 2026.
- Per Business Quant, the three latest AAWH Non-Current Assets figures stand at $683.1 million (Q1 2026), $699.0 million (Q4 2025), and -$208.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 683.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 683.13 Mn |
| Dec 31, 2025 | 698.98 Mn |
| Sep 30, 2025 | -208.81 Mn |
| Jun 30, 2025 | 678.21 Mn |
| Mar 31, 2025 | 679.36 Mn |
| Dec 31, 2024 | 671.06 Mn |
| Sep 30, 2024 | 682.30 Mn |
| Jun 30, 2024 | 693.10 Mn |
| Mar 31, 2024 | 689.82 Mn |
| Dec 31, 2023 | 690.69 Mn |
| Sep 30, 2023 | 696.66 Mn |
| Jun 30, 2023 | 686.42 Mn |
| Mar 31, 2023 | 665.88 Mn |
| Dec 31, 2022 | 673.42 Mn |
| Sep 30, 2022 | 628.12 Mn |
| Jun 30, 2022 | 568.84 Mn |
| Mar 31, 2022 | 453.65 Mn |
| Dec 31, 2021 | 465.42 Mn |
| Sep 30, 2021 | 417.22 Mn |
| Jun 30, 2021 | 389.37 Mn |